|Bid||1.3700 x 1100|
|Ask||1.4300 x 800|
|Day's Range||1.3500 - 1.5180|
|52 Week Range||1.3500 - 7.1300|
|Beta (5Y Monthly)||-0.46|
|PE Ratio (TTM)||0.91|
|Earnings Date||May 10, 2023 - May 15, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.67|
As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So take a...
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company CEO will deliver the keynote address at the 4th Annual MarketsandMarkets Infectious Disease Diagnostics and Molecular Diagnostics Conference, held March 23-24, 2023, in London, England, where the Company will also be hosting a booth.
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note that this event is […]